About the Product

Description


Atmogine 8 Tablet containing Atomoxetine is used for the management of attention deficit hyperactivity disorder (ADHD). It helps in improving attention span, reducing impulsivity, and enhancing behavioral control.

Atomoxetine works by selectively inhibiting the reuptake of norepinephrine in the brain, which helps regulate attention and behavior in patients with ADHD.

The tablet is widely prescribed in pediatric and psychiatric practice, leading to consistent demand and long-term usage in ADHD management.

With increasing awareness and diagnosis of behavioral disorders, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and growing acceptance make it a reliable product for consistent sales and growth in the neuro-psychiatric segment.

Some patients may experience decreased appetite, nausea, dry mouth, dizziness, or sleep disturbances. In some cases, mood changes, increased heart rate, or blood pressure fluctuations may occur. Rarely, serious effects such as suicidal thoughts or liver dysfunction may arise and require immediate medical attention.

Atmogine 8 Tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It helps improve concentration, reduce impulsive behavior, and control hyperactivity, thereby improving daily performance and quality of life.

This medicine should be used under strict medical supervision. Regular monitoring of heart rate, blood pressure, and behavioral changes is recommended. Use with caution in patients with cardiovascular or psychiatric conditions.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Atmogine 8 Tablet in the PCD pharma franchise market?

Atmogine 8 Tablet, containing Atomoxetine 8mg, has demand in the neuropsychiatry and ADHD management segment, making it a specialized but profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS and behavioral healthcare portfolio.

Why should medical distributors include Atmogine 8 Tablet in their product range?

Medical distributors and agencies can benefit from the growing demand for medicines used in attention deficit hyperactivity disorder (ADHD) and related neurobehavioral conditions. Atmogine 8 Tablet helps strengthen a comprehensive neuropsychiatry product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Atmogine 8 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atmogine 8 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Atmogine 8 Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted neuropsychiatry product range when partnering for Atmogine 8 Tablet distribution.

How can I become a distributor or franchise partner for Atmogine 8 Tablet?

Medical distributors, stockists, and wholesalers interested in Atmogine 8 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.